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-0·07 (-0·14 to -0·00)* -0·07 (-0·14 to -0·00) † -0·07 (-0·14 to -0·00) ‡ Phonemic fluency No diabetes ·· ·· ·· Type 2 diabetes -0·10 (-0·18 to -0·01) § -0·09 (-0·18 to -0·01) ¶ -0·09 (-0·17 to 0·00)|| Semantic fluency No diabetes ·· ·· ·· Type 2 diabetes -0·02 (-0·11 to 0·07) -0·02 (-0·10 to 0·07) -0·02 (-0·11 to 0·07) Global score No diabetes ·· ·· ·· Type 2 diabetes -0·08 (-0·16 to -0·01)** -0·09 (-0·16 to -0·01) † † -0·09 (-0·16 to -0·02) ‡ ‡ Data are beta coefficients (95% CI) based on standardised cognitive scores (mean=0, SD=1); -0·00 occurs because of rounding. Data for cognitive function are from 1997-99, 2002-04, and 2007-09 . p values for significant results (p<0·05) compared with reference group are indicated by footnotes. Model 1 is adjusted for age, sex, marital status, and education. Model 2 is adjusted for same parameters as model 1 and health-related behaviours (smoking, alcohol, physical activity, and fruit and vegetable consumption). Model 3 is adjusted for same parameters as model 2 and coronary heart disease, stroke, hypertension, respiratory disease, total cholesterol, obesity, use of antidepressants, and use of lipid-lowering drugs. n for no diabetes is 5351; n for type 2 diabetes is 302. *p=0·048. †p=0·045. ‡p=0·038. §p=0·031. ¶p=0·037. ||p=0·049. **p=0·020. † †p=0·019.
‡ ‡p=0·017. 1997-99, 2002-04, and 2007-09 . Model 1 is adjusted for age, sex, marital status, and education. Model 2 is adjusted for same parameters as model 1 and healthrelated behaviours (smoking, alcohol, physical activity, and fruit and vegetable consumption). Model 3 is adjusted for same parameters as model 2 and coronary heart disease, stroke, hypertension, respiratory disease, total cholesterol, obesity, use of antidepressants, and use of lipid-lowering drugs. n for no diabetes is 409; n for type 2 diabetes is 93. Known diabetes -0·12 (-0·21 to -0·02)** -0·11 (-0·21 to -0·02) † † -0·12 (-0·21 to -0·02) ‡ ‡ Data are beta coefficients (95% CI) based on standardised cognitive scores (mean=0, SD=1); -0·00 occurs because of rounding. Data for cognitive function are from 1997-99, 2002-04, and 2007-09 . p values for significant results (p<0·05) compared with reference group are indicated by footnotes. Model 1 is adjusted for age, sex, marital status, and education. Model 2 is adjusted for same parameters as model 1 and health-related behaviours (smoking, alcohol, physical activity, and fruit and vegetable consumption). Model 3 is adjusted for same parameters as model 2 and coronary heart disease, stroke, hypertension, respiratory disease, total cholesterol, obesity, use of antidepressants, and use of lipid-lowering drugs. n for normoglycaemia is 4703; n for prediabetes is 648; n for newly diagnosed diabetes is 115; and n for known diabetes is 187. *p=0·039.
†p=0·042. ‡p=0·046. §p=0·028. ¶p=0·028. ||p=0·027. **p=0·014. † †p=0·015. ‡ ‡p=0·014. 
-0·11 (-0·20 to -0·02)|| -0·11 (-0·20 to -0·02)** -0·11 (-0·20 to -0·02) † † Data are beta coefficients (95% CI) based on standardised cognitive scores (mean=0, SD=1); -0·00 occurs because of rounding. Model 1 is adjusted for age, sex, marital status, and education. Model 2 is adjusted for same parameters as model 1 and health-related behaviours (smoking, alcohol, physical activity, and fruit and vegetable consumption). Model 3 is adjusted for same parameters as model 2 and coronary heart disease, stroke, hypertension, respiratory disease, total cholesterol, obesity, use of antidepressants, and use of lipid-lowering drugs. n for normoglycaemia is 4622; n for prediabetes is 544; n for newly diagnosed diabetes is 115; and n for known diabetes is 187. *p=0·042. †p=0·043. ‡p=0·030. §p=0·031. ¶p=0·032. ||p=0·016. **p=0·017. † †p=0·021. -0·11 (-0·21 to -0·01) ‡ ‡ -0·11 (-0·20 to -0·01) § § -0·11 (-0·20 to -0·01) ¶ ¶ Data are beta coefficients (95% CI) based on standardised cognitive scores (mean=0, SD=1); -0·00 occurs because of rounding. Model 1 is adjusted for age, sex, marital status, and education. Model 2 is adjusted for same parameters as model 1 and health-related behaviours (smoking, alcohol, physical activity, and fruit and vegetable consumption). Model 3 is adjusted for same parameters as model 2 and coronary heart disease, stroke, hypertension, respiratory disease, total cholesterol, obesity, use of antidepressants, and use of lipid-lowering drugs. n for normoglycaemia is 4703; n for prediabetes is 648; n for diabetes duration ≤1·5 years is 134; and n for diabetes duration >1·5 years is 168. *p=0·042. †p=0·048.
‡p=0·036. §p=0·038. ¶p=0·034. ||p=0·035. **p=0·027. † †p=0·036. ‡ ‡p=0·026. § §p=0·029. ¶ ¶p=0·028. -0·11 (-0·21 to -0·02) ¶ -0·11 (-0·20 to -0·02)|| -0·11 (-0·20 to -0·02)** Data are beta coefficients (95% CI) based on standardised cognitive scores (mean=0, SD=1); -0·00 occurs because of rounding. p values for significant results (p<0·05) compared with reference group are indicated by footnotes. Model 1 is adjusted for age, sex, marital status, and education. Model 2 is adjusted for same parameters as model 1 and health-related behaviours (smoking, alcohol, physical activity, and fruit and vegetable consumption). Model 3 is adjusted for same parameters as model 2 and coronary heart disease, stroke, hypertension, respiratory disease, total cholesterol, obesity, use of antidepressants, and use of lipid-lowering drugs. n for normoglycaemia is 4703; n for prediabetes is 648; n for newly diagnosed diabetes is 115; and n for known diabetes is 187. *p=0·039. †p=0·031. ‡p=0·030. §p=0·009. ¶p=0·015. ||p=0·016. **p=0·020. 
(-0·28 to -0·02) ‡ ‡ Data are beta coefficients (95% CI) based on standardised cognitive scores (mean=0, SD=1). Data for cognitive function are from 1997-99. p values for significant results (p<0·05) compared with reference group are indicated by footnotes. Model 1 is adjusted for age, sex, marital status, and education. Model 2 is adjusted for same parameters as model 1 and health-related behaviours (smoking, alcohol, physical activity, and fruit and vegetable consumption). Model 3 is adjusted for same parameters as model 2 and coronary heart disease, stroke, hypertension, respiratory disease, total cholesterol, obesity, use of antidepressants, and use of lipid-lowering drugs. n for normoglycaemia is 4760; n for prediabetes is 655; n for newly diagnosed diabetes is 116; and n for known diabetes is 192. *p=0·001. †p=0·001. ‡p=0·003. §p=0·015. ¶p=0·018. ||p=0·032. **p=0·005. † †p=0·007. ‡ ‡p=0·021. -0·11 (-0·19 to -0·02)* -0·11 (-0·19 to -0·02) † -0·10 (-0·19 to -0·01) ‡ Data are beta coefficients (95% CI) based on standardised cognitive scores (mean=0, SD=1); -0·00 occurs because of rounding. Data for cognitive function are from 1997-99, 2002-04, and 2007-09 . p values for significant results (p<0·05) compared with reference group are indicated by footnotes. Model 1 is adjusted for age, sex, marital status, and education. Model 2 is adjusted for same parameters as model 1 and health-related behaviours (smoking, alcohol, physical activity, and fruit and vegetable consumption). Model 3 is adjusted for same parameters as model 2 and coronary heart disease, stroke, hypertension, respiratory disease, total cholesterol, obesity, use of antidepressants, and use of lipid-lowering drugs. n for normoglycaemia is 4760; n for prediabetes is 655; n for newly diagnosed diabetes is 116; and n for known diabetes is 192. *p=0·017. †p=0·017. ‡p=0·024. -0·13 (-0·23 to -0·02)* -0·13 (-0·23 to -0·02) † -0·10 (-0·21 to 0·01) Reasoning Normoglycaemia -0·02 (-0·06 to 0·02) -0·01 (-0·05 to 0·03) -0·02 (-0·06 to 0·02) Prediabetes -0·01 (-0·07 to 0·06) -0·00 (-0·07 to 0·06) -0·01 (-0·07 to 0·06) Newly diagnosed diabetes -0·10 (-0·19 to -0·01) ‡ -0·10 (-0·19 to -0·01) § -0·11 (-0·20 to -0·01) ¶ Known diabetes -0·07 (-0·15 to -0·00) -0·08 (-0·15 to -0·00)|| -0·07 (-0·14 to -0·00) Phonemic fluency Normoglycaemia -0·02 (-0·08 to 0·03) -0·02 (-0·07 to 0·03) -0·02 (-0·07 to 0·03) Prediabetes -0·07 (-0·15 to 0·02) -0·06 (-0·15 to 0·02) -0·07 (-0·15 to 0·02) Newly diagnosed diabetes -0·06 (-0·18 to 0·07) -0·05 (-0·18 to 0·07) -0·05 (-0·17 to 0·07) Known diabetes 0·01 (-0·09 to 0·11) 0·01 (-0·09 to 0·11) 0·01 (-0·08 to 0·11) Semantic fluency Normoglycaemia 0·01 (-0·04 to 0·06) 0·02 (-0·04 to 0·07) 0·01 (-0·04 to 0·06) Prediabetes 0·01 (-0·07 to 0·09) 0·02 (-0·06 to 0·10) 0·01 (-0·07 to 0·09) Newly diagnosed diabetes 0·03 (-0·10 to 0·15) 0·03 (-0·09 to 0·16) 0·03 (-0·09 to 0·15) Known diabetes -0·01 (-0·11 to 0·08) -0·02 (-0·11 to 0·08) -0·02 (-0·11 to 0·08) Global score Normoglycaemia -0·01 (-0·05 to 0·03) -0·01 (-0·05 to 0·04) -0·00 (-0·05 to 0·04) Prediabetes -0·05 (-0·11 to 0·02) -0·04 (-0·11 to 0·03) -0·04 (-0·10 to 0·03) Newly diagnosed diabetes -0·07 (-0·18 to 0·03) -0·07 (-0·17 to 0·03) -0·06 (-0·16 to 0·03) Known diabetes -0·06 (-0·14 to 0·02) -0·06 (-0·14 to 0·02) -0·06 (-0·13 to 0·02) Data are beta coefficients (95% CI) based on standardised cognitive scores (mean=0, SD=1); -0·00 occurs because of rounding. Data for cognitive function are from 1997-99, 2002-04, and 2007-09 . p values for significant results (p<0·05) compared with reference group are indicated by footnotes. Model 1 is adjusted for age, sex, marital status, and education. Model 2 is adjusted for same parameters as model 1 and health-related behaviours (smoking, alcohol, physical activity, and fruit and vegetable consumption). Model 3 is adjusted for same parameters as model 2 and coronary heart disease, stroke, hypertension, respiratory disease, total cholesterol, obesity, use of antidepressants, and use of lipid-lowering drugs. n for normoglycaemia is 4336; n for prediabetes is 572; n for newly diagnosed diabetes is 100; and n for known diabetes is 152. *p=0·022. †p=0·020. ‡p=0·039. §p=0·038. ¶p=0·027. ||p=0·040.
